STERIS plc (NYSE:STE) Shares Sold by Atria Wealth Solutions Inc.

Atria Wealth Solutions Inc. trimmed its holdings in STERIS plc (NYSE:STE) by 8.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,187 shares of the medical equipment provider’s stock after selling 112 shares during the period. Atria Wealth Solutions Inc.’s holdings in STERIS were worth $244,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Franklin Resources Inc. lifted its holdings in STERIS by 171.2% in the 3rd quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider’s stock valued at $191,370,000 after purchasing an additional 529,308 shares in the last quarter. Assetmark Inc. lifted its holdings in STERIS by 24.6% in the 3rd quarter. Assetmark Inc. now owns 13,410 shares of the medical equipment provider’s stock valued at $3,252,000 after purchasing an additional 2,647 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its holdings in STERIS by 30.8% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 10,970 shares of the medical equipment provider’s stock valued at $2,275,000 after purchasing an additional 2,583 shares in the last quarter. KBC Group NV lifted its holdings in STERIS by 52.0% in the 3rd quarter. KBC Group NV now owns 12,071 shares of the medical equipment provider’s stock valued at $2,928,000 after purchasing an additional 4,132 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB purchased a new position in STERIS in the 3rd quarter valued at about $9,949,000. 94.69% of the stock is owned by institutional investors and hedge funds.

STERIS Trading Down 0.4 %

NYSE STE opened at $219.23 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13. STERIS plc has a one year low of $197.82 and a one year high of $248.24. The company’s 50 day moving average price is $214.99 and its 200 day moving average price is $223.01. The firm has a market capitalization of $21.54 billion, a price-to-earnings ratio of 46.54 and a beta of 0.84.

STERIS (NYSE:STE) last issued its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. On average, sell-side analysts predict that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be given a $0.57 dividend. This represents a $2.28 annualized dividend and a yield of 1.04%. The ex-dividend date is Thursday, February 20th. STERIS’s dividend payout ratio (DPR) is 48.41%.

Analysts Set New Price Targets

STE has been the topic of several recent analyst reports. JMP Securities reiterated a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a report on Thursday, February 6th. Stephens reiterated an “overweight” rating and set a $240.00 price objective on shares of STERIS in a report on Thursday, February 6th. Needham & Company LLC restated a “hold” rating on shares of STERIS in a report on Friday, November 8th. Finally, Piper Sandler raised their price target on shares of STERIS from $260.00 to $265.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $258.75.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.